NEW YORK (
) -- Several stocks trading near $5 were moving on above-average volume during Monday's session.
surged by $1.34, or 44.7%, to $4.34 ahead of a Friday deadline for the Food and Drug Administration to approve the company's Silenor insomnia drug. Volume topped 8.7 million shares, compared to the 50-day average daily volume of 380,000, according to the Nasdaq.
(TGB - Get Report)
jumped by 38 cents, or 12.3%, to $3.47 after the company it will receive $180 million to joint venture 25% of its Gibraltar Mine with
. Volume topped 4.8 million shares, compared to the three-month average daily volume of 2.1 million, according to Yahoo! Finance.
added 22 cents, or 5.5%, to $4.20 after the
Securities and Exchange Commission
told the company it has completed its investigation and does not recommend any enforcement against Matrixx. In June, the company received an informal inquiry from the SEC related to a warning letter Matrixx received from the FDA. Volume topped 1.1 million shares, compared to the 50-day average daily volume of 502,000, according to the Nasdaq.
jumped by 65 cents, or 11.8%, to $5.17 in the absence of any company-specific news. ZymoGenetics is expected to provide an update at the Piper Jaffray Healthcare Conference on Wednesday. Volume topped 919,000 shares, compared to the 50-day average daily volume of 232,000, according to the Nasdaq.
climbed by 26 cents, or 20%, to $1.57, continuing a two-week surge in shares.
notes that the stock has now tripled since the company upgraded its mineral resource estimate for the Carmen Deposit at its 100% owned Monterde project in Mexico's Sierra Madre mining district on Nov. 18. Volume topped 690,000 million shares, compared to the three-month average daily volume of 121,000, according to Yahoo! Finance.
-- Written by Robert Holmes in New York
Check out all of Monday's high-volume, under-$5 stocks at the Dollar Store
Follow Robert Holmes on
and become a fan of TheStreet.com on